PT - JOURNAL ARTICLE AU - Abhishek Goyal AU - Saurabh Saigal AU - Ankur Joshi AU - Dodda Brahmam AU - Yogesh Niwariya AU - Alkesh Khurana AU - Pooja Singh AU - Sunaina Tejpal Kama AU - Jaiprakash Sharma AU - Sagar Khadanga AU - G Sai Pavan AU - Arun Mitra TI - Whether Early Steroid dose is associated with lower mortality in COVID-19 critically ill Patients- An exploratory chart review AID - 10.1101/2020.08.19.20171868 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.19.20171868 4099 - http://medrxiv.org/content/early/2020/09/11/2020.08.19.20171868.short 4100 - http://medrxiv.org/content/early/2020/09/11/2020.08.19.20171868.full AB - Introduction Steroids have shown its usefulness in critically ill COVID19 patients. However time of starting steroid and dose tailored to severity remains a matter of inquiry due to still emerging evidences and wide-ranging concerns of benefits and harms. We did a retrospective record analysis in an apex teaching hospital ICU setting to explore optimal doses and duration of steroid therapy which can decrease mortality.Methodology 114 adults with COVID19-ARDS admitted to ICU between 20thMarch-15thAugust2020 were included in chart review. We did preliminary exploratory analysis(rooted in steroid therapy matrix categorized by dose and duration) to understand the effect of several covariates on survival. This was followed by univariate and multivariate Cox proportion hazard regression analysis and model diagnostics.Results Exploratory analysis and visualization indicated age, optimal steroid, severity (measured in P/F) of disease and infection status as potential covariates for survival. Univariate cox regression analysis showed significant positive association of age>60 years{2.6 (1.5-4.7)} and protective effect of optimum steroid{0.38(0.2-0.72)} on death (hazard) in critically ill patients. Multivariate cox regression analysis after adjusting effect of age showed protective effect of optimum steroid on hazard defined as death {0.46(0.23-0.87),LR=17.04,(p=2e- 04)}.The concordance was 0.70 and model diagnostics fulfilled the assumption criteria for proportional hazard model.Conclusion Optimal dose steroid as per defined ‘optimum’ (<24 hours and doses tailored to P/F at presentation) criteria can offer protective effect from mortality which persists after adjusting for age. This protective effect was not found to be negatively influenced by the risk of infection.No funding was taken for this paper.Competing Interest StatementThe authors have declared no competing interest.Funding Statementwe did not receive any funding for this project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This retrospective chart review study is part of study titled Predictors of severity in COVID 19 infected patients: Observational Chart review. Institutional Human Ethics Committee (IHEC) approved the protocol vide LOP Number IHEC-LOP/2020/IM0281, dated 15/07/2020.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe have submitted data in the supplement.